Degeneration of neuromuscular junction in age and dystrophy
- PMID: 24904412
- PMCID: PMC4033055
- DOI: 10.3389/fnagi.2014.00099
Degeneration of neuromuscular junction in age and dystrophy
Abstract
Functional denervation is a hallmark of aging sarcopenia as well as of muscular dystrophy. It is thought to be a major factor reducing skeletal muscle mass, particularly in the case of sarcopenia. Neuromuscular junctions (NMJs) serve as the interface between the nervous and skeletal muscular systems, and thus they may receive pathophysiological input of both pre- and post-synaptic origin. Consequently, NMJs are good indicators of motor health on a systemic level. Indeed, upon sarcopenia and dystrophy, NMJs morphologically deteriorate and exhibit altered characteristics of primary signaling molecules, such as nicotinic acetylcholine receptor and agrin. Since a remarkable reversibility of these changes can be observed by exercise, there is significant interest in understanding the molecular mechanisms underlying synaptic deterioration upon aging and dystrophy and how synapses are reset by the aforementioned treatments. Here, we review the literature that describes the phenomena observed at the NMJ in sarcopenic and dystrophic muscle as well as to how these alterations can be reversed and to what extent. In a second part, the current information about molecular machineries underlying these processes is reported.
Keywords: aging; dystrophy; exercise therapy; neuromuscular junction; sarcopenia.
Figures
Similar articles
-
Neuromuscular junction transmission failure in aging and sarcopenia: The nexus of the neurological and muscular systems.Ageing Res Rev. 2023 Aug;89:101966. doi: 10.1016/j.arr.2023.101966. Epub 2023 Jun 1. Ageing Res Rev. 2023. PMID: 37270145 Review.
-
Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.J Neurosci. 2017 Sep 13;37(37):8901-8918. doi: 10.1523/JNEUROSCI.3090-16.2017. Epub 2017 Aug 11. J Neurosci. 2017. PMID: 28821658 Free PMC article.
-
Muscle Fibers Secrete FGFBP1 to Slow Degeneration of Neuromuscular Synapses during Aging and Progression of ALS.J Neurosci. 2017 Jan 4;37(1):70-82. doi: 10.1523/JNEUROSCI.2992-16.2016. J Neurosci. 2017. PMID: 28053031 Free PMC article.
-
The Neuromuscular Junction: Roles in Aging and Neuromuscular Disease.Int J Mol Sci. 2021 Jul 28;22(15):8058. doi: 10.3390/ijms22158058. Int J Mol Sci. 2021. PMID: 34360831 Free PMC article. Review.
-
C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction.Exp Gerontol. 2013 Jan;48(1):76-80. doi: 10.1016/j.exger.2012.05.021. Epub 2012 Jun 7. Exp Gerontol. 2013. PMID: 22683512 Clinical Trial.
Cited by
-
Molecular hallmarks of ageing in amyotrophic lateral sclerosis.Cell Mol Life Sci. 2024 Mar 2;81(1):111. doi: 10.1007/s00018-024-05164-9. Cell Mol Life Sci. 2024. PMID: 38430277 Free PMC article. Review.
-
Peroxisome proliferator-activated receptor γ coactivator 1α regulates downstream of tyrosine kinase-7 (Dok-7) expression important for neuromuscular junction formation.Sci Rep. 2024 Jan 20;14(1):1780. doi: 10.1038/s41598-024-52198-x. Sci Rep. 2024. PMID: 38245592 Free PMC article.
-
The mediating role of inflammaging between mitochondrial dysfunction and sarcopenia in aging: a review.Am J Clin Exp Immunol. 2023 Dec 15;12(6):109-126. eCollection 2023. Am J Clin Exp Immunol. 2023. PMID: 38187366 Free PMC article. Review.
-
The MuSK-BMP pathway regulates synaptic Nav1.4 localization and muscle excitability.bioRxiv [Preprint]. 2023 Oct 29:2023.10.24.563837. doi: 10.1101/2023.10.24.563837. bioRxiv. 2023. PMID: 37961580 Free PMC article. Preprint.
-
Morphological and functional alterations of neuromuscular synapses in a mouse model of ACTA1 congenital myopathy.Hum Mol Genet. 2024 Jan 20;33(3):233-244. doi: 10.1093/hmg/ddad183. Hum Mol Genet. 2024. PMID: 37883471
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
